title: Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Pacanowski
authors.forename: Diane
authors.initials: D
authors.lastname: Bollens
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Poirier
authors.forename: Laurence
authors.initials: L
authors.lastname: Morand-Joubert
authors.forename: Vanina
authors.initials: V
authors.lastname: Castaigne
authors.forename: Pierre-Marie
authors.initials: PM
authors.lastname: Girard
authors.forename: Marie-Caroline
authors.initials: MC
authors.lastname: Meyohas
mesh_terms: D000069454:Darunavir; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir